Literature DB >> 29759541

The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome.

Dan Hu1, Yang Li2, Jiancheng Zhang3, Ryan Pfeiffer4, Michael H Gollob5, Jeff Healey6, Daniel Toshio Harrell7, Naomasa Makita7, Haruhiko Abe8, Yaxun Sun9, Jihong Guo10, Li Zhang11, Ganxin Yan11, Douglas Mah12, Edward P Walsh12, Harris B Leopold13, Carla Giustetto14, Fiorenzo Gaita14, Agnieszka Zienciuk-Krajka15, Andrea Mazzanti16, Silvia G Priori17, Charles Antzelevitch11, Hector Barajas-Martinez18.   

Abstract

OBJECTIVES: This study sought to evaluate the phenotypic and functional expression of an apparent hotspot mutation associated with short QT syndrome (SQTS).
BACKGROUND: SQTS is a rare channelopathy associated with a high risk of life-threatening arrhythmias and sudden cardiac death (SCD).
METHODS: Probands diagnosed with SQTS and their family members were evaluated clinically and genetically. KCNH2 wild-type (WT) and mutant genes were transiently expressed in HEK293 cells, and currents were recorded using whole-cell patch clamp and action potential (AP) clamp techniques.
RESULTS: KCNH2-T618I was identified in 18 members of 7 unrelated families (10 men; median age: 24.0 years). All carriers showed 100% penetrance with variable expressivity. Eighteen members in 7 families had SCD. The average QTc intervals of probands and all carriers was 294.1 ± 23.8 ms and 313.2 ± 23.8 ms, respectively. Seven carriers received an implantable cardioverter-defibrillator. Quinidine with adequate plasma levels was effective in prolonging QTc intervals among 5 cases, but 3 cases still had premature ventricular contraction or nonsustained ventricular tachycardia. Bepridil successfully prevented drug-refractory ventricular fibrillation in 1 case with 19-ms prolongation of the QTc interval. Functional studies with KCNE2 revealed a significant increase of IKr (rapidly activating delayed rectifier potassium channel) tail-current density in homozygous (119.0%) and heterozygous (74.6%) expression compared with WT. AP clamp recordings showed IKr was larger, and peak repolarizing current occurred earlier in mutant versus WT channels.
CONCLUSIONS: We reported the clinical characteristics and biophysical properties of the highly frequent mutation that contributes to genetically identified SQTS probands. These findings extend our understanding of the spectrum of KCNH2 channel defects in SQTS.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  channelopathy; genetics; short QT syndrome; sudden cardiac death; therapy

Mesh:

Substances:

Year:  2017        PMID: 29759541     DOI: 10.1016/j.jacep.2016.11.013

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  14 in total

1.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

Review 2.  Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.

Authors:  Joshua A Keefe; Oliver M Moore; Kevin S Ho; Xander H T Wehrens
Journal:  Arch Toxicol       Date:  2022-10-10       Impact factor: 6.168

3.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

4.  Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles.

Authors:  Dominic G Whittaker; Haibo Ni; Alan P Benson; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2017-10-04       Impact factor: 4.566

Review 5.  Recent Advances in Short QT Syndrome.

Authors:  Oscar Campuzano; Georgia Sarquella-Brugada; Sergi Cesar; Elena Arbelo; Josep Brugada; Ramon Brugada
Journal:  Front Cardiovasc Med       Date:  2018-10-29

6.  Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome.

Authors:  Andrew Butler; Yihong Zhang; A Graham Stuart; Christopher E Dempsey; Jules C Hancox
Journal:  Heliyon       Date:  2019-04-20

7.  Human Atrial Arrhythmogenesis and Sinus Bradycardia in KCNQ1-Linked Short QT Syndrome: Insights From Computational Modelling.

Authors:  Dominic G Whittaker; Michael A Colman; Haibo Ni; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2018-10-04       Impact factor: 4.566

8.  In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome.

Authors:  Dominic G Whittaker; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2019-01-11       Impact factor: 4.566

9.  Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis.

Authors:  Laura S Raschwitz; Ibrahim El-Battrawy; Kim Schlentrich; Johanna Besler; Michael Veith; Gretje Roterberg; Volker Liebe; Rainer Schimpf; Siegfried Lang; Christian Wolpert; Xiaobo Zhou; Ibrahim Akin; Martin Borggrefe
Journal:  Front Genet       Date:  2020-01-17       Impact factor: 4.599

10.  Susceptibility to Ventricular Arrhythmias Resulting from Mutations in FKBP1B, PXDNL, and SCN9A Evaluated in hiPSC Cardiomyocytes.

Authors:  Hector Barajas-Martinez; Maya Smith; Dan Hu; Robert J Goodrow; Colleen Puleo; Can Hasdemir; Charles Antzelevitch; Ryan Pfeiffer; Jacqueline A Treat; Jonathan M Cordeiro
Journal:  Stem Cells Int       Date:  2020-09-01       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.